 NEW YORK, Dec. 09, 2020 GLOBE NEWSWIRE -- Predictive Oncology NASDAQ: POAI, a knowledge-driven company focused on applying artificial intelligence AI to personalized medicine and drug discovery, today sent a letter to shareholders regarding its virtual Special Meeting of Stockholders, original scheduled for December 1, 2020, which will be reconvened December 30, 2020 at 3 p.m. CST. 